logo
Select company
Select metric
-1638.71%Return on Equity
VS
Market
1
Sector
2
Industry
5
History
-
$ 0.83Close
$ 0.67 - $ 6.3 52-Week Range
Ticker Information

Ticker

ISPC

Company Name

ISPECIMEN INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

ISPECIMEN INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ISPC - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 621.97K$ -10.19M-1638.71%
3/31/2025$ 1.67M$ -11.25M-674.5%
12/31/2024$ 3.31M$ -12.5M-377.46%
9/30/2024$ 4.71M$ -9.52M-202.01%
6/30/2024$ 6.09M$ -10.2M-167.43%
3/31/2024$ 6.81M$ -11.57M-169.81%
12/31/2023$ 9.74M$ -11.1M-113.95%
9/30/2023$ 12.71M$ -10.19M-80.17%
6/30/2023$ 14.71M$ -11.17M-75.94%
3/31/2023$ 18.08M$ -10.29M-56.92%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ISPECIMEN INC's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, ISPECIMEN INC's average ROE has been -249.55%.
  • The median ROE for ISPECIMEN INC during this period was -80.17%
  • ISPECIMEN INC reached its highest ROE over the past 5 years at -26.68%.
  • The lowest ROE recorded by ISPECIMEN INC in the same timeframe -1638.71%

ISPECIMEN INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
BIAF : BIOAFFINITY TECHNOLOGIES INC -BNBX : APPLIED DNA SCIENCES INC -929.6%IVF : INVO FERTILITY INC -1071.39%INM : INMED PHARMACEUTICALS INC -60.76%BMRA : BIOMERICA INC -121.14%CPHI : CHINA PHARMA HOLDINGS INC -56.58%NUWE : NUWELLIS INC -NBY : NOVABAY PHARMACEUTICALS INC 54.63%HIND : VYOME HOLDINGS INC -77.17%NDRA : ENDRA LIFE SCIENCES INC -595.01%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for ISPECIMEN INC is calculated as follows: Net Inc. Cmn. [ $ -4.65M ] / Equity [ $ -27.28M ]
(=) ROE [ 0% ]

ISPC - Return on Equity, Last 5 years

-1638.71%

Minimum

Jun 30, 2025

-26.68%

Maximum

Mar 31, 2022

-249.55%

Average

-80.17%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%